Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 2903
TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384552BDBM384552(US10285982, Compound 8)
Affinity DataEC50:  73nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384555BDBM384555(US10285982, Compound 20)
Affinity DataEC50:  97nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384703BDBM384703(US10285982, Compound 328)
Affinity DataEC50:  121nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384668BDBM384668(US10285982, Compound 66)
Affinity DataEC50:  139nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384614BDBM384614(US10285982, Compound 44)
Affinity DataEC50:  144nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384596BDBM384596(US10285982, Compound 40)
Affinity DataEC50:  223nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384672BDBM384672(US10285982, Compound 84)
Affinity DataEC50:  279nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384671BDBM384671(US10285982, Compound 79)
Affinity DataEC50:  359nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384567BDBM384567(US10285982, Compound 30)
Affinity DataEC50:  444nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384710BDBM384710(US10285982, Compound 533)
Affinity DataEC50:  456nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384562BDBM384562(US10285982, Compound 27)
Affinity DataEC50:  507nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384670BDBM384670(US10285982, Compound 75)
Affinity DataEC50:  542nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384705BDBM384705(US10285982, Compound 364)
Affinity DataEC50:  630nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384585BDBM384585(US10285982, Compound 33)
Affinity DataEC50:  642nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384586BDBM384586(US10285982, Compound 37)
Affinity DataEC50:  671nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384624BDBM384624(US10285982, Compound 49)
Affinity DataEC50:  747nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384688BDBM384688(US10285982, Compound 177)
Affinity DataEC50:  867nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384716BDBM384716(US10285982, Compound 701)
Affinity DataEC50:  1.06E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384551BDBM384551(US10285982, Compound 4)
Affinity DataEC50:  1.21E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384692BDBM384692(US10285982, Compound 188)
Affinity DataEC50:  1.23E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384701BDBM384701(US10285982, Compound 278)
Affinity DataEC50:  1.35E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384689BDBM384689(US10285982, Compound 180)
Affinity DataEC50:  1.63E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384687BDBM384687(US10285982, Compound 172)
Affinity DataEC50:  2.24E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384673BDBM384673(US10285982, Compound 90)
Affinity DataEC50:  3.20E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384691BDBM384691(US10285982, Compound 184)
Affinity DataEC50:  3.24E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384704BDBM384704(US10285982, Compound 351)
Affinity DataEC50:  6.90E+3nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384682BDBM384682(US10285982, Compound 122)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384681BDBM384681(US10285982, Compound 117)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384680BDBM384680(US10285982, Compound 114)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384679BDBM384679(US10285982, Compound 111)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384686BDBM384686(US10285982, Compound 140)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384685BDBM384685(US10285982, Compound 135)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384684BDBM384684(US10285982, Compound 133)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384683BDBM384683(US10285982, Compound 125)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384674BDBM384674(US10285982, Compound 92)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384678BDBM384678(US10285982, Compound 103)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384677BDBM384677(US10285982, Compound 98)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384676BDBM384676(US10285982, Compound 96)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384675BDBM384675(US10285982, Compound 95)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384698BDBM384698(US10285982, Compound 263)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384697BDBM384697(US10285982, Compound 262)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384696BDBM384696(US10285982, Compound 256)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384695BDBM384695(US10285982, Compound 254)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384702BDBM384702(US10285982, Compound 311)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384700BDBM384700(US10285982, Compound 275)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384699BDBM384699(US10285982, Compound 272)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384690BDBM384690(US10285982, Compound 182)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384694BDBM384694(US10285982, Compound 249)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384693BDBM384693(US10285982, Compound 231)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 384714BDBM384714(US10285982, Compound 641)
Affinity DataEC50: >1.00E+4nMAssay Description:Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., colon cancer) or primary cells (e.g., IEC-6 intestinal cells) wit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: